Bio-Alcamid in drug-induced lipodystrophy.
The development of new drugs to counter human immunodeficiency virus (HIV) infection has led to an increase in lipodystrophic syndrome among HIV-infected individuals receiving combination therapy. Bio-Alcamid(TM) is a recently developed polymeric substance that can be implanted to compensate for adipose effects. We have implanted this substance in 73 patients with up to three years' follow-up. The aesthetic results were deemed excellent by both physicians and patients. No implant dislocation, implant migration, granuloma, allergic reaction or intolerance were recorded.
Protopapa
Carmelo
C
Department of Plastic Surgery, University of Parma, Parma, Italy.
Sito
Giuseppe
G
Caporale
Domenico
D
Cammarota
Nazzareno
N
D000180:Acrylic Resins / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D005260:Female; D006679:HIV Seropositivity / Q000150:complications; D006801:Humans; D008060:Lipodystrophy / Q000209:etiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D019736:Prostheses and Implants
D000180:Acrylic Resins; C470344:Bio-Alcamid